2018
Considering Spine Surgery
Moulton H, Tosteson TD, Zhao W, Pearson L, Mycek K, Scherer E, Weinstein JN, Pearson A, Abdu W, Schwarz S, Kelly M, McGuire K, Milam A, Lurie JD. Considering Spine Surgery. Spine 2018, 43: 1731-1738. PMID: 29877995, PMCID: PMC6279474, DOI: 10.1097/brs.0000000000002723.Peer-Reviewed Original ResearchConceptsTreatment optionsPatient participantsTreatment outcomesKnowledge scoreIntervertebral disc herniationComprehensive decision aidWeb-based calculatorNonsurgical treatmentDegenerative spondylolisthesisSpinal stenosisSpine centerBack surgeryClinical evidenceDisc herniationProspective evaluationProspective mannerSpine surgeryBACKGROUND DATAIndividualized riskInitial appointmentDecisional conflictTrial dataIndividualized toolSurgeryOutcomes
2017
Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer
Kandimalla R, Linnekamp JF, van Hooff S, Castells A, Llor X, Andreu M, Jover R, Goel A, Medema JP. Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer. Oncogenesis 2017, 6: e308-e308. PMID: 28368388, PMCID: PMC5520503, DOI: 10.1038/oncsis.2017.9.Peer-Reviewed Original ResearchConsensus molecular subtype 4Stage II colon cancerAdjuvant therapyCC patientsColon cancerRecurrence predictionWnt target gene Axin2Stage II CC patientsPoor recurrence-free survivalPoor prognosis patientsRecurrence-free survivalCpG island methylatorGene methylationPrognosis patientsCC cohortCenter cohortWorse prognosisClinical parametersPositive cancersValidation cohortMethylation-specific PCRPrognostic markerProspective mannerSubtype tumorsPrognostic biomarker
2005
Voice Restoration With the Advantage Tracheoesophageal Voice Prosthesis
Leder S, Acton L, Kmiecik J, Ganz C, Blom E. Voice Restoration With the Advantage Tracheoesophageal Voice Prosthesis. Otolaryngology 2005, 133: 681-684. PMID: 16274792, DOI: 10.1016/j.otohns.2005.08.009.Peer-Reviewed Original ResearchConceptsOral antifungal agentsTracheoesophageal voice prosthesisGroup 1Group 3Group 2Clinic visitsVoice prosthesisAntifungal agentsYears 8 monthsYears 10 monthsIndwelling voice prosthesisHealth care systemRoutine careMajority of participantsProspective mannerLife spanDay 3Voice restorationDevice failureBlom-SingerStudy designDevice life spanCare systemMonthsFlap valve
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply